听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览ONCOGENE期刊下所有文献
  • The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.

    abstract::The microenvironment of glioblastoma (GBM) contains high levels of inflammatory cytokine interleukin 6 (IL-6), which contributes to promote tumour progression and invasion. The common epidermal growth factor receptor variant III (EGFRvIII) mutation in GBM is associated with significantly higher levels of IL-6. Further...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.225

    authors: Gurgis FM,Yeung YT,Tang MX,Heng B,Buckland M,Ammit AJ,Haapasalo J,Haapasalo H,Guillemin GJ,Grewal T,Munoz L

    更新日期:2015-05-28 00:00:00

  • TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.

    abstract::Tripartite motif 24 protein (TRIM24) is a plant homeodomain/bromodomain histone reader, recently associated with poor overall survival of breast-cancer patients. At a molecular level, TRIM24 is a negative regulator of p53 levels and a co-activator of estrogen receptor. However, the role of TRIM24 in breast tumorigenes...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.220

    authors: Pathiraja TN,Thakkar KN,Jiang S,Stratton S,Liu Z,Gagea M,Shi X,Shah PK,Phan L,Lee MH,Andersen J,Stampfer M,Barton MC

    更新日期:2015-05-28 00:00:00

  • DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.

    abstract::Cancer stem cell (CSC), the primary source of cancer-initiating population, is involved in cancer recurrence and drug-resistant phenotypes. This study demonstrates that the loss of DAB2IP, a novel Ras-GTPase activating protein frequently found in many cancer types, is associated with CSC properties. Mechanistically, D...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.215

    authors: Yun EJ,Baek ST,Xie D,Tseng SF,Dobin T,Hernandez E,Zhou J,Zhang L,Yang J,Sun H,Xiao G,He D,Kittler R,Hsieh JT

    更新日期:2015-05-21 00:00:00

  • MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.

    abstract::Gastric cancer (GC) is one of the most common tumors and the molecular mechanism underlying its metastasis is still largely unclear. Here, we show that miR-25 was overexpressed in plasma and primary tumor tissues of GC patients with tumor node metastasis stage (III or IV) or lymph node metastasis. MiR-25 inhibition si...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.214

    authors: Li BS,Zuo QF,Zhao YL,Xiao B,Zhuang Y,Mao XH,Wu C,Yang SM,Zeng H,Zou QM,Guo G

    更新日期:2015-05-14 00:00:00

  • MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.

    abstract::Oncogenic RAS promotes production of reactive oxygen species (ROS), which mediate pro-malignant signaling but can also trigger DNA damage-induced tumor suppression. Thus RAS-driven tumor cells require redox-protective mechanisms to mitigate the damaging aspects of ROS. Here, we show that MutT Homolog 1 (MTH1), the mam...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.195

    authors: Patel A,Burton DG,Halvorsen K,Balkan W,Reiner T,Perez-Stable C,Cohen A,Munoz A,Giribaldi MG,Singh S,Robbins DJ,Nguyen DM,Rai P

    更新日期:2015-05-14 00:00:00

  • Polyoma small T antigen triggers cell death via mitotic catastrophe.

    abstract::Polyoma small T antigen (PyST), an early gene product of the polyoma virus, has been shown to cause cell death in a number of mammalian cells in a protein phosphatase 2A (PP2A)-dependent manner. In the current study, using a cell line featuring regulated expression of PyST, we found that PyST arrests cells in mitosis....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.192

    authors: Pores Fernando AT,Andrabi S,Cizmecioglu O,Zhu C,Livingston DM,Higgins JM,Schaffhausen BS,Roberts TM

    更新日期:2015-05-07 00:00:00

  • Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption.

    abstract::Heat shock protein (Hsp)90 regulates many key pathways in oncogenesis, including Akt and mammalian target of rapamycin (mTOR). The strengths of disruption of Hsp90 in cancer therapy include their versatility in inhibiting a wide range of oncogenic pathways. The present study demonstrated that synuclein γ (SNCG) protec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.126

    authors: Liang W,Miao S,Zhang B,He S,Shou C,Manivel P,Krishna R,Chen Y,Shi YE

    更新日期:2015-04-30 00:00:00

  • Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.

    abstract::The molecular basis for the resistance of tumor cells to cell-mediated cytotoxicity remains poorly understood and thus poses a major challenge for cancer immunotherapy. The present study was designed to determine whether the WNT1-inducible signaling pathway protein 2 (WISP2, also referred to as CCN5), a key regulator ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.151

    authors: Akalay I,Tan TZ,Kumar P,Janji B,Mami-Chouaib F,Charpy C,Vielh P,Larsen AK,Thiery JP,Sabbah M,Chouaib S

    更新日期:2015-04-23 00:00:00

  • Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells.

    abstract::Somatic alterations of fibroblast growth factor receptors (FGFRs) have been described in a wide range of malignancies. A number of anti-FGFR therapies are currently under investigation in clinical trials for subjects with FGFR gene amplifications, mutations and translocations. Here, we develop cell line models of acqu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.161

    authors: Wang J,Mikse O,Liao RG,Li Y,Tan L,Janne PA,Gray NS,Wong KK,Hammerman PS

    更新日期:2015-04-23 00:00:00

  • Stem cell programs are retained in human leukemic lymphoblasts.

    abstract::Leukemic lymphoblasts within different immunophenotypic populations possess stem cell properties. However, whether or not the self-renewal program is retained from stem cells or conferred on progenitors by leukemogenic molecules remains unknown. We have addressed the issue in the context of TEL-AML1-associated acute l...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.148

    authors: Fan D,Zhou X,Li Z,Li ZQ,Duan C,Liu T,Zhang F,Huang Y,Zhang Y,Gao F,Guo Y,Gupta R,Chen G,Enver T,Tang J,Hong D

    更新日期:2015-04-16 00:00:00

  • Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.

    abstract::Lysyl oxidase (LOX) is a multifunctional protein required for normal collagen and elastin biosynthesis and maturation. In addition, LOX has complex roles in cancer in which the lysyl oxidase propeptide (LOX-PP) domain of secreted pro-LOX has tumor-suppressor activity, while the active enzyme promotes metastasis. In pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.147

    authors: Bais MV,Ozdener GB,Sonenshein GE,Trackman PC

    更新日期:2015-04-09 00:00:00

  • The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.

    abstract::Only humans and higher primates have high uric acid blood levels. Although high uric acid causes gout, it has been linked with human longevity because of its hypothetical antioxidant function. Recent studies reveal that p53 has significant roles in cellular metabolism. One example of this is an antioxidant function th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.119

    authors: Itahana Y,Han R,Barbier S,Lei Z,Rozen S,Itahana K

    更新日期:2015-04-02 00:00:00

  • Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.

    abstract::Talins are adaptor proteins that regulate focal adhesion signaling by conjugating integrins to the cytoskeleton. Talins directly bind integrins and are essential for integrin activation. We previously showed that β1 integrins are activated in metastatic prostate cancer (PCa) cells, increasing PCa metastasis to lymph n...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.116

    authors: Jin JK,Tien PC,Cheng CJ,Song JH,Huang C,Lin SH,Gallick GE

    更新日期:2015-04-02 00:00:00

  • Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells.

    abstract::Ubiquilin1 (UBQLN1) is a ubiquitin-like domain and a ubiquitin-associated domain containing protein that has been reported to be involved in shuttling proteins to the proteasome, especially during endoplasmic reticulum-associated protein degradation. Thus, UBQLN1 function has been shown to be critical for combating a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.97

    authors: Shah PP,Lockwood WW,Saurabh K,Kurlawala Z,Shannon SP,Waigel S,Zacharias W,Beverly LJ

    更新日期:2015-03-26 00:00:00

  • Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

    abstract::Emerging evidence has shown that cancer stem cells (CSCs) are the cellular determinants to promote cancer invasion and metastasis. However, the mechanism underlying CSC invasion remains unknown. MicroRNAs are evolutionally conserved small noncoding RNAs that are critical for the regulation of gene expression, and thei...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.75

    authors: Wang Z,Wang B,Shi Y,Xu C,Xiao HL,Ma LN,Xu SL,Yang L,Wang QL,Dang WQ,Cui W,Yu SC,Ping YF,Cui YH,Kung HF,Qian C,Zhang X,Bian XW

    更新日期:2015-03-12 00:00:00

  • A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation.

    abstract::The tumor suppressor gene Pdcd4 (programmed cell death gene 4) has drawn considerable attention because its downregulation is involved in the development of several types of cancer. Because Pdcd4 interacts with the translation initiation factor eIF4A and inhibits its helicase activity, Pdcd4 has been implicated in the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.83

    authors: Biyanee A,Ohnheiser J,Singh P,Klempnauer KH

    更新日期:2015-03-12 00:00:00

  • Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism.

    abstract::Hec1 (highly expressed in cancer 1) or Nek2 (NIMA-related kinase 2) is often overexpressed in cancers with poor prognosis. Both are critical mitotic regulators, and phosphorylation of Hec1 S165 by Nek2 is required for proper chromosome segregation. Therefore, inactivation of Hec1 and Nek2 by targeting their interactio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.67

    authors: Hu CM,Zhu J,Guo XE,Chen W,Qiu XL,Ngo B,Chien R,Wang YV,Tsai CY,Wu G,Kim Y,Lopez R,Chamberlin AR,Lee EY,Lee WH

    更新日期:2015-03-05 00:00:00

  • PKA signaling drives mammary tumorigenesis through Src.

    abstract::Protein kinase A (PKA) hyperactivation causes hereditary endocrine neoplasias; however, its role in sporadic epithelial cancers is unknown. Here, we show that heightened PKA activity in the mammary epithelium generates tumors. Mammary-restricted biallelic ablation of Prkar1a, which encodes for the critical type-I PKA ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.41

    authors: Beristain AG,Molyneux SD,Joshi PA,Pomroy NC,Di Grappa MA,Chang MC,Kirschner LS,Privé GG,Pujana MA,Khokha R

    更新日期:2015-02-26 00:00:00

  • The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants.

    abstract::Recent studies suggest that medulloblastoma, the most common malignant brain tumor of childhood, is comprised of four disease variants. The WIP1 oncogene is overexpressed in Group 3 and 4 tumors, which contain medulloblastomas with the most aggressive clinical behavior. Our data demonstrate increased WIP1 expression i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.37

    authors: Buss MC,Remke M,Lee J,Gandhi K,Schniederjan MJ,Kool M,Northcott PA,Pfister SM,Taylor MD,Castellino RC

    更新日期:2015-02-26 00:00:00

  • Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility.

    abstract::Epithelial-to-mesenchymal transition (EMT) promotes cell motility, which is important for the metastasis of malignant cells, and blocks CD95-mediated apoptotic signaling triggered by immune cells and chemotherapeutic regimens. CD95L, the cognate ligand of CD95, can be cleaved by metalloproteases and released as a solu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.55

    authors: Edmond V,Dufour F,Poiroux G,Shoji K,Malleter M,Fouqué A,Tauzin S,Rimokh R,Sergent O,Penna A,Dupuy A,Levade T,Theret N,Micheau O,Ségui B,Legembre P

    更新日期:2015-02-19 00:00:00

  • The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers.

    abstract::Polymorphisms and somatic mutations in Flap Endonuclease 1 (FEN1), an essential enzyme involved in DNA replication and repair, can lead to functional deficiencies of the FEN1 protein and a predisposition to cancer. We identified a FEN1 germline mutation that changed residue E359 to K in a patient whose family had a hi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.19

    authors: Chung L,Onyango D,Guo Z,Jia P,Dai H,Liu S,Zhou M,Lin W,Pang I,Li H,Yuan YC,Huang Q,Zheng L,Lopes J,Nicolas A,Chai W,Raz D,Reckamp KL,Shen B

    更新日期:2015-02-12 00:00:00

  • TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

    abstract::Metastatic growth in breast cancer (BC) has been proposed as an exclusive property of cancer stem cells (CSCs). However, formal proof of their identity as cells of origin of recurrences at distant sites and the molecular events that may contribute to tumor cell dissemination and metastasis development are yet to be el...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.5

    authors: Bartucci M,Dattilo R,Moriconi C,Pagliuca A,Mottolese M,Federici G,Benedetto AD,Todaro M,Stassi G,Sperati F,Amabile MI,Pilozzi E,Patrizii M,Biffoni M,Maugeri-Saccà M,Piccolo S,De Maria R

    更新日期:2015-02-05 00:00:00

  • The stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells.

    abstract::Several common biological properties between cancer cells and embryonic stem (ES) cells suggest the possibility that some genes expressed in ES cells might have important roles in cancer cell growth. The transcription factor ZFP57 is expressed in self-renewing ES cells and its expression level decreases during ES cell...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.599

    authors: Tada Y,Yamaguchi Y,Kinjo T,Song X,Akagi T,Takamura H,Ohta T,Yokota T,Koide H

    更新日期:2015-02-05 00:00:00

  • Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.

    abstract::The maintenance cytosine DNA methyltransferase DNMT1 and de novo methyltransferase DNMT3b cooperate to establish aberrant DNA methylation and chromatin complexes to repress gene transcription during cancer development. The expression of DNMT3b was constitutively increased 5-20-fold in hTERT/CDK4-immortalized human bro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.580

    authors: Teneng I,Tellez CS,Picchi MA,Klinge DM,Yingling CM,Snider AM,Liu Y,Belinsky SA

    更新日期:2015-01-29 00:00:00

  • Delaying mitotic exit downregulates FLIP expression and strongly sensitizes tumor cells to TRAIL.

    abstract::Many of the current antitumor therapeutic strategies are based on the perturbation of the cell cycle, especially during mitosis. Antimitotic drugs trigger mitotic checkpoint activation, mitotic arrest and eventually cell death. However, mitotic slippage represents a major mechanism of resistance to these treatments. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.601

    authors: Sánchez-Pérez T,Medema RH,López-Rivas A

    更新日期:2015-01-29 00:00:00

  • Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation.

    abstract::EZH2 (enhancer of zeste homolog 2) is a critical enzymatic subunit of the polycomb repressive complex 2 (PRC2), which trimethylates histone H3 (H3K27) to mediate gene repression. Somatic mutations, overexpression and hyperactivation of EZH2 have been implicated in the pathogenesis of several forms of cancer. In partic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.571

    authors: Sahasrabuddhe AA,Chen X,Chung F,Velusamy T,Lim MS,Elenitoba-Johnson KS

    更新日期:2015-01-22 00:00:00

  • Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells.

    abstract::Aromatase inhibitors (AIs) are the standard endocrine therapy for postmenopausal breast cancer; however, currently used biomarkers, such as, estrogen receptor-alpha/progesterone receptor (ERα/PR), predict only slightly more than half of the potential responders to AI treatment. To identify novel markers of AI responsi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.553

    authors: Moy I,Todorović V,Dubash AD,Coon JS,Parker JB,Buranapramest M,Huang CC,Zhao H,Green KJ,Bulun SE

    更新日期:2015-01-15 00:00:00

  • The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration.

    abstract::Rac1-GTPases serve as intermediary cellular switches, which conduct transient and constitutive signals from upstream cues, including those from Ras oncoproteins. Although the sirtuin1 (SIRT1) deacetylase is overexpressed in several human cancers and has recently been linked to cancer cell motility as a context-depende...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.549

    authors: Saxena M,Dykes SS,Malyarchuk S,Wang AE,Cardelli JA,Pruitt K

    更新日期:2015-01-08 00:00:00

  • TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    abstract::Transforming growth factor-beta (TGF-β) is a pleiotropic cytokine with the capability to act as tumour suppressor or tumour promoter depending on the cellular context. TGF-beta receptor type-2 (TGFBR2) is the ligand-binding receptor for all members of the TGF-β family. Data from mouse model experiments demonstrated th...

    journal_title:Oncogene

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/onc.2013.527

    authors: Busch S,Acar A,Magnusson Y,Gregersson P,Rydén L,Landberg G

    更新日期:2015-01-02 00:00:00

  • Alternative splicing in cancer: implications for biology and therapy.

    abstract::Alternative splicing has critical roles in normal development and can promote growth and survival in cancer. Aberrant splicing, the production of noncanonical and cancer-specific mRNA transcripts, can lead to loss-of-function in tumor suppressors or activation of oncogenes and cancer pathways. Emerging data suggest th...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.570

    authors: Chen J,Weiss WA

    更新日期:2015-01-02 00:00:00

  • Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.

    abstract::Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional acti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.508

    authors: Robinson JL,Hickey TE,Warren AY,Vowler SL,Carroll T,Lamb AD,Papoutsoglou N,Neal DE,Tilley WD,Carroll JS

    更新日期:2014-12-11 00:00:00

  • Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.

    abstract::The discovery of constitutive nuclear factor-κB (NF-κB) activation in Hodgkin's lymphoma tumor cells almost two decades ago was one of the first reports that directly connected deregulated NF-κB signaling to human cancer. Subsequent studies demonstrated that enhanced NF-κB signaling is a common hallmark of many lympho...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.565

    authors: Nagel D,Vincendeau M,Eitelhuber AC,Krappmann D

    更新日期:2014-12-11 00:00:00

  • An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer.

    abstract::Lineage-restricted transcription factors (TFs) are frequently mutated or overexpressed in cancer and contribute toward malignant behaviors; however, the molecular bases of their oncogenic properties are largely unknown. As TF activities are difficult to inhibit directly with small molecules, the genes and pathways the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.517

    authors: Sulahian R,Casey F,Shen J,Qian ZR,Shin H,Ogino S,Weir BA,Vazquez F,Liu XS,Hahn WC,Bass AJ,Chan V,Shivdasani RA

    更新日期:2014-12-04 00:00:00

  • SALL4, a novel marker for human gastric carcinogenesis and metastasis.

    abstract::SALL4, a zinc-finger transcriptional factor for embryonic stem cell self-renewal and pluripotency, has been suggested to be involved in tumorigenesis. The role of SALL4 in human gastric cancer, however, remains largely unknown. In this study, we demonstrated that SALL4 was aberrantly expressed at both mRNA and protein...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.495

    authors: Zhang L,Xu Z,Xu X,Zhang B,Wu H,Wang M,Zhang X,Yang T,Cai J,Yan Y,Mao F,Zhu W,Shao Q,Qian H,Xu W

    更新日期:2014-11-27 00:00:00

  • Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition.

    abstract::RAS-driven malignancies remain a major therapeutic challenge. The two-stage 7,12-dimethylbenz(a)anthracene (DMBA)/12-o-tetradecanoylphorbol-13-acetate (TPA) model of mouse skin carcinogenesis has been used to study mechanisms of epithelial tumor development by oncogenic Hras. We used mice with an Hras(G12V) knock-in a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.489

    authors: Chen X,Makarewicz JM,Knauf JA,Johnson LK,Fagin JA

    更新日期:2014-11-20 00:00:00

  • Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells.

    abstract::We show that expression of the microtubule depolymerizing kinesin KIF2C is induced by transformation of immortalized human bronchial epithelial cells (HBEC) by expression of K-Ras(G12V) and knockdown of p53. Further investigation demonstrates that this is due to the K-Ras/ERK1/2 MAPK pathway, as loss of p53 had little...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.486

    authors: Zaganjor E,Osborne JK,Weil LM,Diaz-Martinez LA,Gonzales JX,Singel SM,Larsen JE,Girard L,Minna JD,Cobb MH

    更新日期:2014-11-20 00:00:00

  • Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.

    abstract::SAG (Sensitive to Apoptosis Gene), also known as RBX2 or ROC2, is a RING protein required for the activity of Cullin-RING ligase (CRL). Our recent study showed that Sag total knockout caused embryonic lethality at E11.5-12.5 days with associated defects in vasculogenesis. Whether Sag is required for de novo vasculogen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.473

    authors: Tan M,Li H,Sun Y

    更新日期:2014-10-30 00:00:00

  • Mode of action of trabectedin in myxoid liposarcomas.

    abstract::To elucidate the mechanisms behind the high sensitivity of myxoid/round cell liposarcoma (MRCL) to trabectedin and the suggested selectivity for specific subtypes, we have developed and characterized three MRCL xenografts, namely ML017, ML015 and ML004 differing for the break point of the fusion gene FUS-CHOP, respect...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.462

    authors: Di Giandomenico S,Frapolli R,Bello E,Uboldi S,Licandro SA,Marchini S,Beltrame L,Brich S,Mauro V,Tamborini E,Pilotti S,Casali PG,Grosso F,Sanfilippo R,Gronchi A,Mantovani R,Gatta R,Galmarini CM,Sousa-Faro JM,D'Incalc

    更新日期:2014-10-30 00:00:00

  • Essential roles of Crk and CrkL in fibroblast structure and motility.

    abstract::Cytosolic proteins containing SH2 and SH3 domains, such as Crk and Crk-like (CrkL), are broadly expressed adapters that interact with a variety of proteins to fulfill key roles in signal transduction pathways triggered by activation of receptor and non-receptor tyrosine kinases. Crk and CrkL are similar to each other ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.453

    authors: Park TJ,Curran T

    更新日期:2014-10-23 00:00:00

  • Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo.

    abstract::Mesenchymal stem cells (MSCs) are a kind of adult stem cells that can be isolated easily from bone marrow, adipose tissue, umbilical cord and many other tissues. MSCs have been shown to specifically migrate to inflammatory sites, including tumors, and hold great promise as tumor-specific vectors to deliver antitumor a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.458

    authors: Xu C,Lin L,Cao G,Chen Q,Shou P,Huang Y,Han Y,Wang Y,Shi Y

    更新日期:2014-10-16 00:00:00

2007 条记录 9/51 页 « 12...6789101112...5051 »